Oxidized Low-Density Lipoproteins Impair Endothelial Function by Inhibiting Non-Genomic Action of Thyroid Hormone–Mediated Nitric Oxide Production in Human Endothelial Cells-Reference-Cited by-同舟云学术

Oxidized Low-Density Lipoproteins Impair Endothelial Function by Inhibiting Non-Genomic Action of Thyroid Hormone–Mediated Nitric Oxide Production in Human Endothelial Cells

Published:2013-02 Issue:2 Volume:23 Page:231-238
ISSN:1050-7256
Container-title:Thyroid
language:en
Short-container-title:Thyroid

Author:

Vicinanza Roberto¹,Coppotelli Giuseppe¹²,Malacrino Carolina¹,Nardo Tiziana¹,Buchetti Barbara¹,Lenti Luisa¹,Celi Francesco S.³,Scarpa Susanna¹

Affiliation:

1. Department of Experimental Medicine, Sapienza University of Rome, Rome, Italy.

2. Department of Cell and Molecular Biology, Karolinska Institutet, Stockholm, Sweden.

3. Clinical Endocrinology Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland.

Publisher

Mary Ann Liebert Inc

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

https://www.liebertpub.com/doi/pdf/10.1089/thy.2011.0524

Reference41 articles.

1. Thyroid hormones and the cardiovascular system: Pathophysiology and interventions

2. Thyroid Hormone Action in the Heart

3. Role of thyroid receptor β in lipid metabolism

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hypothyroidism and metabolic cardiovascular disease;Frontiers in Endocrinology;2024-06-03

2. Cardiovascular outcomes in subclinical thyroid disease: an update;Current Opinion in Endocrinology, Diabetes & Obesity;2023-06-08

3. Assessment of the association between genetic factors regulating thyroid function and microvascular complications in diabetes: A two-sample Mendelian randomization study in the European population;Frontiers in Endocrinology;2023-02-28

4. Association of Thyroid Hormone Levels with Microvascular Complications in Euthyroid Type 2 Diabetes Mellitus Patients;Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy;2022-08

5. Thyroid disorders and cardiovascular manifestations: an update;Endocrine;2022-01-15